Pfizer Inc. (NYSE:PFE), revealed that it was looking to acquire British pharmaceutical company, AstraZeneca, for $100 billion. However, the US pharmaceutical giant has so far been turned down twice. Pfizer Inc. (NYSE:PFE), shares after opening at $32..06 moved to $32.09 on last trade day and at the end of the day closed at $31.76. Company price to sales ratio in past twelve months was calculated as 3.94 and price to cash ratio as 6.27. Pfizer Inc. (NYSE:PFE), showed a positive weekly performance of 2.45%.
Bristol-Myers Squibb Co (NYSE:BMY), reported first higher first quarter earnings, which came in above analysts’ estimates. The company also announced that it has acquired IPierian. Bristol-Myers Squibb Co (NYSE:BMY), shares fell 2.07% in last trading session and ended the day on $49.32. Bristol-Myers Squibb Co (NYSE:BMY), return on equity ratio is recorded as 17.70% and its return on assets is 6.90%. Bristol-Myers Squibb Co (NYSE:BMY), yearly performance is 27.21%.
AstraZeneca plc (ADR) (NYSE:AZN), shares jumped 15% on news of the latest takeover plan, which would be the biggest-ever foreign acquisition of a British company and one of the largest-ever pharmaceuticals deals. AstraZeneca plc (ADR) (NYSE:AZN), shares moved up 0.13% in last trading session and was closed at $77.11, while trading in range of $ 77.05 – 78.74. AstraZeneca plc (ADR) (NYSE:AZN), year to date (YTD) performance is 33.62%.
Johnson & Johnson has suspended the sale of power morcellators after the FDA recently issued warning of higher risk of cancer due to the surgical procedure. The FDA had urged medical experts to avoid using power morcellators as there was high risk of some hidden cancer uterine sarcoma causing the spread of cancer to abdomen and pelvis. Johnson & Johnson (NYSE:JNJ), weekly performance is 0.85%. On last trading day company shares ended up $101.03. Johnson & Johnson (NYSE:JNJ), distance from 50-day simple moving average (SMA50) is 5.78%. Analysts mean target Price for the company is $104.55.
Leave a Reply